COGR expresses concerns to the U.S. Army Medical Research and Development Command's Animal Care and Use Review Office (ACURO) regarding a new policy that, effective…
Research Compliance
Information and analysis to foster compliance with regulatory requirements governing the conduct of various types of sponsored research such as human subjects research, laboratory animal research, and research using regulated substances or agents.
Featured
COGR Matrix of Laws, Regulations, and Policies Regarding Science & Security
COGR has developed a comprehensive chart that summarizes and compares federal laws, regulations, and policies in the area of science and security.
Updated: Quick Reference Table of Current & Upcoming Federal Research Security Requirements
The document presents a detailed overview of current and forthcoming federal research security requirements as they pertain to federally funded research activities…
ARIO and COGR Post Tools for Finalizing Institutional Research Misconduct Policies to Comply with Updated PHS Regulations at 42 CFR Part 93
Joint ARIO and COGR working groups have developed several tools to assist institutions in revising their research misconduct policies t
UPDATED: Summary of Recent Significant Updates to the NIH Genomic Data Sharing Policy
This document summarizes significant recent updates to the NIH Genomic Data Sharing (GDS) Policy, focusing on new and stricter cybersecurity requirements and access...
Research Security and the Cost of Compliance—Phase I Report, Disclosure Requirements Now Available
COGR conducted Phase I of the survey described in this report to quantify the considerable time and resources (financial and otherwise) that research institutions
Resources
Point of Contact
Kristin West
Director, Research Ethics & Compliance
All Research Compliance Articles
NIH’s Implementation of the U.S. Government Policy on Dual Use Research of Concern and Pathogens with Enhanced Pandemic Potential
The document outlines the implications and implementation procedures stemming from the newly issued NIH policy (NOT-OD-25-061) on oversight of Dual Use Research of Concern (DURC) and Pathogens with Enhanced Pandemic Potential (PEPP). Effective May 6, 2025, this policy consolidates and supersedes previous federal regulations, broadening the range of biological agents and experimental categories req
COGR Joins Coalition Statement in Support of Research Using Human Fetal Tissue
The coalition statement expresses strong support from a broad array of scientific, medical, and patient advocacy organizations for the continued use of human fetal tissue (HFT) in biomedical research. The statement underscores the critical role HFT has played in enabling significant scientific and clinical advances, including the development of vital vaccines (such as those for polio, rubella, and
Joint Association & Institutional Letter to President Trump on Fetal Tissue Research Restrictions and COVID-19
The letter, dated March 25, 2020, is a joint appeal from numerous leading scientific, medical, and patient advocacy organizations to President Donald J. Trump. The signatories urge a reconsideration and immediate lifting of federal restrictions on research involving human fetal tissue, emphasizing the critical role such research plays in developing treatments and vaccines during the COVID-19 pande
